Fusobacterium necrophorum causes Lemierre's syndrome, a rare, life-threatening disease described in 1936 by Lemierre [1] . F. necrophorum is also associated strongly with peritonsillar abscess and has recently been connected with tonsillitis [2] [3] [4] . F. necrophorum is traditionally described as forming part of the normal flora of the oropharynx, gastrointestinal tract and genitourinary tract of humans, but convincing evidence is lacking [5] . Recent studies using PCR or cloning and sequencing of 16S rRNA genes have failed to detect F. necrophorum on throat swabs from healthy controls [2, 6] .
F. necrophorum is divided into two subspecies: F. necrophorum subsp. necrophorum and F. necrophorum subsp. funduliforme. The necrophorum subspecies is associated mostly with infections in domestic mammals, whereas subsp. funduliforme infects mainly humans [7, 8] . Molecular techniques, e.g., 16S)23S rRNA intergenic spacer region sequence analysis, random amplified polymorphic DNA-PCR and ribotyping analysis, have been developed to discriminate between the two subspecies [9] [10] [11] [12] , and real-time PCR analysis has been shown to have potential for detecting F. necrophorum [2] .
The present study describes the use of a TaqMan-based real-time quantitative PCR assay, targeting the gyrB gene, to detect and discriminate between the two subspecies of F. necrophorum in the throats of healthy volunteers, and to examine the possible role of F. necrophorum in non-streptococcal tonsillitis (NST). The possible role of group C streptococci (GCS) in F. necrophorum tonsillitis was also evaluated.
M A T E R I A L S A N D M E T H O D S Sample collection, preparation and culturing
Between June 2005 and January 2006, 146 throat swabs from patients aged 18-32 years were sent to the microbiological laboratory at Viborg Hospital, Viborg, Denmark, for routine detection of bacterial throat pathogens. A diagnosis of tonsillitis required the presence of sore throat, inflamed tonsils and at least one of the following: fever; enlarged tender lymphatic glands on the neck; or elevated C-reactive protein. Acute tonsillitis was defined as a single episode, whereas recurrent tonsillitis included recurrent acute episodes, relapses within 1 month, and persistent cases with a duration of >1 month. Each diagnosis of tonsillitis was discussed with the responsible clinicians by a single infectious diseases specialist, who was blinded from the PCR and bacteriological results.
Of the 146 throat swabs, 41 were from febrile patients with infections other than tonsillitis, patients with other throat diseases, and healthy individuals who were tested because of infected family members. In total, 105 throat swabs were from patients who fulfilled the criteria for tonsillitis. Forty cases had tonsillitis associated with haemolytic streptococci, six with group A streptococci (GAS), 26 with GCS, four with group F streptococci, and four with group G streptococci. The majority of the throat swabs were received from general practitioners. Most general practitioners in Denmark use rapid immunoassay kits to detect GAS, thus indicating that most of the throat swabs required analysis for pathogenic throat bacteria other than GAS.
There were 65 patients with NST, four of whom were patients with confirmed acute mononucleosis and were therefore excluded. The remaining 61 patients with NST comprised 39 females and 22 males (median age 25 years), of whom 43 and 18 had acute or recurrent NST, respectively. A control group consisted of 42 healthy female student nurses and 50 healthy male soldiers, aged 18-32 years (median age 22 years), who had neither suffered from a sore throat nor received antibiotic therapy in the preceding 2-week period.
Swabs were transported in Stuart's Transport Medium (Statens Serum Institut (SSI), Copenhagen, Denmark) within 24 h of being taken. They were then inoculated on Columbia agar plates containing sheep blood (Becton Dickinson, Heidelberg, Germany) 5% v ⁄ v and incubated overnight at 35°C in CO 2 5% v ⁄ v, and also on plates containing horse blood (SSI) 5% v ⁄ v that were incubated at 35°C in anaerobic jars containing an atmosphere of CO 2 5%, H 2 10%, N 2 85% v ⁄ v. Plates were examined after incubation for 1, 2 and 4 days. Throat swabs were stored for up to 2 days at 4°C until extraction of bacterial DNA.
Bacterial identification by culture
Initial identification of F. necrophorum was based on colony morphology, an odour of butyric acid, the presence of a greenish fluorescence from colonies when irradiated with UV light, and a characteristic Gram-negative pleomorphic morphology under the microscope, supplemented by susceptibility to kanamycin and metronidazole on primary inoculated agar plates. Subsequent b-haemolysis on agar containing horse blood 5% v ⁄ v, resistance to vancomycin and susceptibility to polymyxin confirmed the identification of F. necrophorum [13] . F. necrophorum isolates were not identified to the subspecies level by culture. b-Haemolytic streptococci were identified by colony and cell morphology, as well by haemolysis on Columbia agar containing sheep blood 5% v ⁄ v. Lancefield groups were determined using a Slidex Strepto-Kit (bio-Mérieux, Marcy l'Etoile, France) [14] .
DNA extraction
Bacterial DNA was isolated by vortexing the swabs in 1 mL of physiological saline for 1 min and then extracting the nucleic acid from 200 lL of saline using the Kingfisher mL magnetic particle processor (Thermo Electron Corporation, Waltham, MA, USA) and a Biosprint 15 DNA Blood Kit (Qiagen, Westburg, The Netherlands), both according to the manufacturers' instructions. Nucleic acids were eluted in 200 lL of the elution buffer supplied with the extraction kit, and were then stored at 4°C until use.
Design of primers and probes
A subspecies-specific real-time quantitative PCR assay was developed for the purpose of detecting and discriminating between F. necrophorum subsp. necrophorum and subsp. funduliforme. The assay was based on published gyrB sequences [15] . A primer pair targeting both subspecies, and two subspecies-specific TaqMan probes, were designed by multiple alignment analysis using the sequence alignment editor BioEdit, and six gyrB sequences of subsp. necrophorum and four gyrB sequences of subsp. funduliforme available in GenBank (http://www.ncbi.nlm.nih.gov) [16, 17] . The potential primers and probes were analysed for the requirements imposed by real-time PCR using the PrimerQuest program (http://scitools.idtdna.com/Primerquest/). Finally, the chosen primers and probes were analysed for specificity against GenBank sequences with the BLAST program package (http://www.ncbi.nlm.nih.gov/BLAST) [18] . Primer pair gyrB-forward, 5¢-AGGATTGCATGGAGTAGGAA (positions 27-46), and gyrB-reverse, 5¢-CCTATTTCATTTCGACAATCCA (positions 332-311), amplify a 306-bp fragment from both subspecies. The subsp. necrophorum-specific probe, 5¢-TCTAC-TTTGGAGGTTGGAGAAACAAC (positions 160-185), was labelled at the 5¢ end with 6-carboxyfluorescein, and at the 3¢ end with Black Hole Quencher 1, whereas the subsp. funduliforme-specific probe, 5¢-TCCGCTTTAGAGGCTGGAG-AAACGAC (positions 160-185), was labelled at the 5¢ end with hexachlorofluorescein and at the 3¢ end with Black Hole Quencher 2. The assay was carried out in two separate PCRs.
To verify the results of the gyrB assay at the species level, an F. necrophorum species-specific real-time PCR assay, modified for TaqMan chemistry, was employed [2] . This assay was based on the amplification of a 277-bp fragment of the RNA polymerase b-subunit (rpoB) gene using the primers RPO-forward, 5¢-TCTCTACGTATGCCTCACGGATC (positions 171-193), and RPO-reverse, 5¢-CGATATTCATCCGAGAGGGTCTC (positions 447-424) [2, 12] . The TaqMan probe was designed using PrimerQuest, yielding RPO-probe, 5¢-TTGCCGGCGGAA GACATGCCTTTCTTA (positions 167-193). The probe was labelled at the 5¢ end with 6-carboxyfluorescein and at the 3¢ end with Black Hole Quencher 1.
TaqMan qPCR
The PCRs for both assays were carried out in 25-lL reaction mixtures containing 12.5 lL of 2 · Brilliant QPCR Master Mix (Stratagene, La Jolla, CA, USA), 2.5 lL of 100 nM (final concentration) TaqMan probe, 2.5 lL of 300 or 400 nM (final concentrations) forward and reverse primer, for the rpoB and gyrB assays, respectively, and 5 lL of template DNA. Primers and probes were synthesised by Proligo (Paris, France). Thermal cycling on an Mx3000P Real Time PCR System (Stratagene) comprised 10 min at 95°C, followed by 55 cycles of 30 s at 95°C and 60 s at 60°C for both assays. All samples were run in duplicate. DNA extracted from F. necrophorum subsp. necrophorum ATCC 25286 and subsp. funduliforme ATCC 51357 served as positive controls and were included in each PCR run. Sterile water was added to a PCR instead of template as a negative control. In addition, sterile swabs were processed as described above and were used as templates in order to control for contamination in the extraction procedure. Results were analysed using the Mx3000P software package (Stratagene).
Assay sensitivity and specificity
The detection limit of the gyrB assay was determined using ten-fold serial dilutions of a known concentration (1.5 · 10 0 to 1.5 · 10 8 CFU ⁄ mL) of F. necrophorum subsp. necrophorum ATCC 25286 and subsp. funduliforme ATCC 51357 in PCRs as described above. The species specificity of the assays was tested using DNA from a variety of bacteria, including several strains of both subspecies of F. necrophorum, as well as other Fusobacterium spp., pharyngeal pathogens and commensal flora of the pharynx ( Table 1) .
Quantification of bacterial load in positive swabs
Quantification of F. necrophorum subsp. funduliforme DNA in positive swabs was performed by including a ten-fold serial dilution of known concentrations of F. necrophorum subsp. funduliforme ATCC 51357 (1.5 · 10 0 to 1.5 · 10 8 CFU ⁄ mL) in the gyrB assay analysis.
DNA sequence analysis
PCR products in the gyrB assay from five human throat swabs (two controls and three patients with NST), as well as DNA from four F. necrophorum subsp. necrophorum isolates of veterinary origin, were sequenced on a 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). Sequencing was carried out using an ABI Prism Big Dye terminator v.1.1 Ready Reaction Cycle Sequencing kit (Applied Biosystems) according to the manufacturer's instructions. PCR products were sequenced in both directions using both primers of the gyrB assay. Sequences were subsequently subjected to a BLAST search analysis to confirm the source as either F. necrophorum subsp. necrophorum or F. necrophorum subsp. funduliforme.
Statistics
Differences among groups were examined using the Kruskal-Wallis test for multi-group comparison, while the Wilcoxon rank sum test was used for two-group comparisons. In addition, chi-square values and ORs were calculated for the PCR results between healthy controls and cases of NST, as well as between cases of NST and patients with GCS tonsillitis. PCR-negative swabs were given a value of 1 CFU ⁄ swab for statistical purposes. Statistical significance was defined as p <0.05. Statistical analyses were performed using SPSS for Windows v.13.0 (SPSS Inc., Chicago, IL, USA). 
GenBank accession numbers

R E S U L T S Assay sensitivity
The gyrB assay was linear for both subspecies over the range 1.5 · 10 3 -1.5 · 10 8 CFU ⁄ swab (= CFU ⁄ mL), corresponding to a threshold cycle (C T ) ranging from 26.6 to 44.0 and from 26.0 to 43.6 cycles for F. necrophorum subsp. necrophorum and subsp. funduliforme, respectively. The R 2 values were 0.992 (Y = )3.48X + 55.62) and 0.988 (Y = )3.45X + 55.69) for subsp. funduliforme and subsp. necrophorum, respectively. The minimum detection limit of the assays for both subspecies was between 1.5 · 10 2 and 1.5 · 10 3 CFU ⁄ swab (0.75 and 7.5 CFU ⁄ reaction). 
Species specificity of assay
DNA sequence analysis
The sequences of the five PCR products amplified from throat swabs were almost identical, with one sequence differing from the other four by two bases. The four sequences amplified from F. necrophorum subsp. necrophorum isolates of veterinary origin were identical. BLAST analysis of the sequences confirmed the specificity of the gyrB assay, with the DNA sequences amplified from the throat swabs having the highest similarity with known sequences of F. necrophorum subsp. funduliforme (AY370669, AY370668, AY37667 and AY370665), and DNA sequences amplified from DNA from veterinary isolates of subsp. necrophorum having the highest similarity with known sequences of F. necrophorum subsp. necrophorum (AY372007, AY370663, AY370662, AY370666, AY370661 and AY370664).
Throat swab analysis
PCR detected the presence of F. necrophorum DNA on 29 (48%) of 61 swabs from patients with NST, and on 19 (21%) of 92 swabs from healthy controls ( Table 2 ). The gyrB assay identified all PCR-positive swabs in both the control and the NST groups as F. necrophorum subsp. funduliforme.
No conflicting results were found between the two real-time PCR assays. An overall non-parametric multi-group comparison revealed a significant difference between test groups (p <0.001) (Fig. 1a ). Furthermore, a non-parametric two-group analysis revealed a significant difference between healthy controls and NST patients (p <0.001), and between NST patients and patients with tonsillitis harbouring GCS (p <0.001) (Fig. 1a ). In addition, there was a significant difference in the number of PCRpositive swabs from healthy controls and NST patients (p <0.001, OR 3.9, 95% CI 1.7-7.1), and from NST patients and patients with GCS tonsillitis (p 0.02, OR 3.0, 95% CI 1.1-8.1). No differences in the load of F. necrophorum DNA were found between swabs from NST patients and swabs from patients with streptococci other than GCS by non-parametric multi-group and nonparametric two-group analysis (data not shown). Furthermore, the load of F. necrophorum DNA on the 41 non-tonsillitis throat swabs, of which 11 were PCR-positive, was equivalent to that of the healthy controls (data not shown).
When NST was divided into acute NST and recurrent NST, the load of F. necrophorum DNA was significantly greater for patients with recurrent NST compared to acute NST (p 0.04) ( Fig. 1b) , but there was no difference in the number of PCR-positive swabs from acute NST and recurrent NST patients (p 0.4, OR 1.6, 95% CI 0.5-4.8). NST, non-streptococcal tonsillitis; GCS, group C streptococci.
Growth of F. necrophorum occurred, by anaerobic culture, from two swabs in the NST group but from none in the control group. In addition, five swabs from patients with tonsillitis that were culture-positive for GCS were also culturepositive for F. necrophorum. All culture-positive swabs had higher levels of F. necrophorum DNA than did swabs from controls. Three of the excluded swabs from patients with acute mononucleosis were positive for F. necrophorum by PCR, with one also being positive for F. necrophorum by culture.
D I S C U S S I O N
The results of this study confirmed that F. necrophorum subsp. funduliforme is part of the normal flora of the human tonsils. Previous studies have failed to detect F. necrophorum DNA from the tonsils of healthy humans [2, 6] . Aliyu et al. [2] used a real-time PCR assay targeting rpoB, and did not detect F. necrophorum in healthy controls, but found F. necrophorum in 10% of patients with a 'sore throat'. Aas et al. [6] did not detect F. necrophorum on tonsils from five individuals aged 23-55 years by sequencing 16S rRNA genes from the total sample DNA. It was therefore surprising to detect F. necrophorum DNA on swabs from healthy individuals in the present study. However, the findings seem to be reliable, as both real-time PCR assays yielded consistent results, and sequencing of amplicons from both the control and patient groups showed homology with F. necrophorum subsp. funduliforme sequences. F. necrophorum probably resides in small numbers, mainly in the crypts of the tonsil in healthy humans, but is present on the surface of inflamed tonsils in higher numbers. This makes it difficult to detect F. necrophorum in healthy individuals if swabs are taken only from the surface of the tonsils.
The low incidence of F. necrophorum revealed by culture in the present study was probably a consequence of the fact that the general anaerobic agar medium used in Denmark is not very effective for detecting F. necrophorum. As a result of this study, all throat swabs in this hospital are now cultured anaerobically on anaerobic agar plates supplemented with horse blood 5% v ⁄ v, nalidixic acid 5.0 mg ⁄ L and vancomycin 2.5 mg ⁄ L, and F. necrophorum is now isolated from >15% of throat swabs from tonsillitis patients aged 18-32 years.
F. necrophorum subsp. funduliforme was the only subspecies found in both the control and the patient groups, which is in agreement with the general assumption and previous findings that subsp. funduliforme is the subspecies found in humans [2, 19] .
Although the aetiology and pathogenesis of tonsillitis are complex, and viruses may also play an important role, the present data indicate that F. necrophorum subsp. funduliforme causes acute NST, especially recurrent NST, and may account for some of the cases of tonsillitis considered previously to be of viral aetiology. Batty et al. isolated F. necrophorum more frequently from patients with persistent 'sore throat' than from patients with acute tonsillitis. F. necrophorum is a commensal pathogen known to cause peritonsillar abscesses as well as Lemierre's syndrome, and it therefore seems plausible that F. necrophorum can also cause tonsillitis. The trigger for F. necrophorum to cause tonsillitis, or lead to the development of peritonsillar abscess or Lemierre's syndrome, is unknown, but genetic precursors may be involved [20] . Further studies are required to reveal the mechanisms involved in the transition from a local F. necrophorum infection of the tonsils to Lemierre's syndrome.
F. necrophorum rarely penetrates intact mucosal surfaces. Therefore, interaction with viruses and other bacteria has been suggested as a precursor for F. necrophorum infection [21, 22] . Epstein-Barr virus has been suspected to be a predisposing factor for F. necrophorum infection, especially Lemierre's syndrome [23, 24] . Epstein-Barr virus is thought to induce immunosuppression, with a transient decrease in T-cell-mediated immunity that may predispose to bacterial infection. In the present study, three of four cases of acute mononucleosis were PCR-positive for F. necrophorum. There may be a connection between F. necrophorum infection and acute mononucleosis, but a study with sufficient samples has yet to be conducted.
An association was found between F. necrophorum subsp. funduliforme and GCS in patients with tonsillitis. Such an association was not found between F. necrophorum and other Lancefield groups of streptococci. However, the sample sizes for other groups of streptococcal tonsillitis were small, and results regarding GAS may be biased because of the frequent use of GAS diagnostic kits by general practitioners. To our knowledge, the present study is the first to suggest a pathogenic connection between F. necrophorum and GCS, although a few examples of co-infections with F. necrophorum and GCS have been reported previously [25, 26] . Blossom et al. [27] recently reported a classic case of Lemierre's syndrome caused by GCS alone. Although F. necrophorum was not detected, it might have been overlooked because of the delayed growth of F. necrophorum compared to GCS in blood cultures. The present data suggest a synergic relationship between F. necrophorum subsp. funduliforme and GCS in tonsillitis, but further research on this topic is required. In the meantime, it is suggested that all patients with signs of bacterial tonsillitis be examined for F. necrophorum.
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